A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer

Purpose and significance:With the increasing incidence of Diabetes mellitus (DM), the incidence rate of Diabetic Foot (DF) is raised. DF is a foot infection, ulceration and / or deep tissue destruction caused by nerve abnormalities and varying degrees of vascular lesions in DM patients. The high incidence, disability and mortality rate of DF make it urgent to explore new ways to improve the cure rate, reduce the burden and elevate the quality of life. Previous studies have confirmed that traditional Miao ethic medicine Tangningtongluo(TNTL) can improve the remission rate of diabetes mellitus and diabetic foot disease, but the clinical research evidence is not sufficient. This study aims to provide effective clinical evidence for the treatment of diabetic foot patients with TNTL by observing growth rate of wound, prognosis and outcome.

Methods: From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed.

Type of study: randomized controlled, prospective,intervention study.

Study Overview

• Status: Recruiting
• Conditions: Diabetic Foot Ulcer
• Intervention / Treatment: Drug: Standardized Western Medicine Treatment; Drug: Tangningtongluo tablet and cream; Drug: Tangningtongluo tablet; Drug: Tangningtongluo cream

Detailed Description

From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed.

• Study Type: Interventional
• Enrollment (Anticipated): 80
• Phase: Phase 1

Contacts and Locations

Study Locations

• China
  • Jiangsu
    • Nantong, Jiangsu, China, 226001
      • Recruiting
      • Gu Yunjuan
      • Contact: Gu Yunjuan, M.D/Ph.D; Phone Number: +8615851207860; Email: desette@ntu.edu.cn

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Clinical diagnosis of Type 2 diabetes mellitus
• Clinical diagnosis of Diabetic Foot Ulcer

Exclusion Criteria:

• Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia
• TNTL allergy
• Chronic kidney failure（eGFR≤30ml/min/1.73cm2）, severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors
• Recent acute complications of type 2 diabetes mellitus（ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.）or other emergency situations
• History of using glucocorticoids and immunosuppressants
• Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required
• Malignant ulcer

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Standardized Western Medicine Treatment Group; All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).	Drug: Standardized Western Medicine Treatment; Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.; Other Names: Classic Diabetic Foot Ulcer treatment
Experimental: Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group; Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.	Drug: Standardized Western Medicine Treatment; Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.; Other Names: Classic Diabetic Foot Ulcer treatment; Drug: Tangningtongluo tablet and cream; Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.There are two dosage forms: tablet and cream.; Other Names: Tangningtongluo Pian and Tangningtongluo Gao
Experimental: Standardized Western Medicine Treatment +TNTL tablet Group; Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.	Drug: Standardized Western Medicine Treatment; Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.; Other Names: Classic Diabetic Foot Ulcer treatment; Drug: Tangningtongluo tablet; Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use tablet.; Other Names: Tangningtongluo Pian
Experimental: Standardized Western Medicine Treatment +TNTL cream Group; Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.	Drug: Standardized Western Medicine Treatment; Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.; Other Names: Classic Diabetic Foot Ulcer treatment; Drug: Tangningtongluo cream; Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use cream.; Other Names: Tangningtongluo Gao

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Decrease area of wound healing due to Diabetic Foot Ulcer	Assessment the decrease of whole area of diabetic foot ulcers. The unit is square centimeters .	12 weeks
Decrease of depth of ulcer involve the deep fascia.	Measurement of depth of ulcer involve the deep fascia. The unit is millimeters.	12 weeks
Amputation Rate	The difference of end-stage amputation rates between the experimental group and the control group were evaluated by the arterial and venous blood circulation of the lower limbs	12 weeks
Diabetic Foot Ulcer relapse rate	The relapse of Diabetic Foot Ulcers is a common complication in the advanced stage of DFU. The difference of treatment between the experimental group and the control group indicates that the prognosis is variability.	12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fasting glucose	10 hours after fasting peripheral blood glucose level, and the unit is mmol/L	12 weeks
2-H postload glucose	2 hours after peripheral blood glucose level eating 75g glucose or 100g steamed bread, and the unit is mmol/L	12 weeks
BMI Index	The calculation formula of Body Mass Index is: BMI = weight ÷ height 2. (weight in kilograms; height in meters.)	12 weeks
WHR Index	Waist to hip ratio (WHR) = waist / hip.Waist circumference or minimum waist circumference shall be used for measurement, and evaluation of WHR is an important value to central obesity.	12 weeks
Islet B cell function	The ability of islet B cells to secrete insulin was reflected by the level of C peptide, which is measured after fasting. The unit is ng/dL .	12 weeks
interleukin-6(IL-6)	Determine the level of interleukin-6(IL-6) in peripheral blood by ELISA, the unit is ng/L.	12 weeks
tumour necrosis factor-α(TNF-α)	Determine the level of TNF-α in peripheral blood , the unit is ng/ml.	12 weeks
C-reactive protein(CRP)	Determine the level of C-reactive protein(CRP) in peripheral blood , the unit is μg/L.	12 weeks

Collaborators and Investigators

• Sponsor: Affiliated Hospital of Nantong University

Study record dates

Study Major Dates

• Study Start (Actual): January 15, 2022
• Primary Completion (Anticipated): December 30, 2022
• Study Completion (Anticipated): March 31, 2023

Study Registration Dates

• First Submitted: September 2, 2021
• First Submitted That Met QC Criteria: December 2, 2021
• First Posted (Actual): December 6, 2021

Study Record Updates

• Last Update Posted (Actual): March 18, 2022
• Last Update Submitted That Met QC Criteria: March 4, 2022
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Cardiovascular Diseases; Vascular Diseases; Skin Diseases; Endocrine System Diseases; Diabetic Angiopathies; Leg Ulcer; Skin Ulcer; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Foot Diseases; Diabetic Foot; Foot Ulcer; Ulcer
• Other Study ID Numbers: TNTL on diabetic foot ulcer

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No